Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2012


COPD: Novel Therapeutics & Management Strategies

22 Oct 2012 - 23 Oct 2012 - London, England



Bookmark and Share


SMi is proud to present their 4th annual conference on COPD, with presentations from the biggest players in the field. This year’s event promises to be a perfect forum for discussions and debates with key opinion leaders from industry and academia. 

Key Benefits of Attending:

· Consider developments in the modelling and management of exacerbations of COPD 

· Evaluate unique complexities of COPD pathophysiology 

· Develop combination and oxygen therapies within COPD - learn about triple therapies and novel therapies within the treatment of COPD 

· Hear from leading industry professionals on the current clinical trials process and rapid proof of concept studies

· Analyse all phases of the discovery process, from pre-clinical modelling, phase 2 studies all the way through to modelling clinical outcomes

· Network with and learn from key industry professional and research leading academics 

· Discuss the latest in health economics for COPD drugs

For more information visit http://www.smi-online.co.uk/goto/copd-conference8.asp otherwise contact Fateja Begum on tel +44 0 207 827 6184 or email on fbegum@smi-online.co.uk 



Further information
Scientific News
Cell Transplant Treats Parkinson’s in Mice
A University of Wisconsin—Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell.
Understanding Female HIV Transmission
Glowing virus maps points of entry through entire female reproductive tract for first time.
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
Common Class of Cancer Drugs May Not Lead to Cognitive Decline
UCLA study refutes 2015 research suggesting anthracyclines could cause memory loss, other impairments.
Designing Better Drugs
A rational drug engineering approach could breathe new life into drug development.
Genetic Approach May Lead to New Treatments for Digestive Diseases
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
Potential Target for Revolutionary Antibiotics
An international team of including the Lomonosov Moscow State University researchers discovered which enzyme enables Escherichia coli bacterium (E. coli) to breathe.
Unique Model for Studying ALS
Unique mouse model will allow researchers to better study the genetic origins and potential treatments of ALS.
Factors Influencing Influenza Vaccine Effectiveness Uncovered
The long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited, new research suggests.
New Model to Enhance Zika Virus Research
The model will allow researchers to better understand how the virus causes disease and aid in the development of antiviral compounds and vaccines.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!